Amcor Launched Enhanced-Stock Product Program for North America Healthcare Market

Amcor, a leader in developing and producing responsible pharmaceutical and medical packaging, is pleased to announce the launch of an enhanced-stock product program for the healthcare market.

The program allows customers to order from a set of market-recognized DuPontTM Tyvek® pouches and Breather Bag® header bags, available with low minimum-order quantities.

These materials are ideal for cost-competitive applications, Class I, II and III devices and products requiring value cleanroom production and strong puncture- and abrasion- resistance.

“Throughout the pandemic, our customers have taken on projects to produce swabs, test kits and ancillary supplies related to treating COVID-19, while investing in equipment and new capabilities,” said Don Alip, healthcare product excellence director, Amcor. “Our customers rely on Amcor’s trusted, proven, versatile solutions to deliver peace of mind and protect patients through a variety of applications.”

The enhanced-stock product program reportedly enables delivery of the high performance and responsiveness of industry-recognized Tyvek pouches and breather bags to customers. The program also supports Amcor’s ability to meet industry demand surges related to the specific products highlighted.

For more information, visit https://www.amcor.com.

Share on Socials!

Related Articles

Related Articles

New Sinamics G115D Distributed Drive System Specifically Designed for Conveyor Applications

With its new Sinamics G115D, Siemens is introducing a new, compact and powerful drive system specifically designed for horizontal conveyor applications. The drive system comprises the ...
Read More

Asynchronous deposited bag conveyor doubles products per minute

This system tackles both speed and position control - very cool. Winneconne, WI - Multi-Conveyor (http://www.multi-conveyor.com/) - Multi-Conveyor has just built this 2:1 mild steel constructed ...
Read More

Convenience and Availability Push E-Pharma Market Growth

The global e-pharma market is expected to reach U.S. $109.2 billion by 2025, according to a new report by Grand View Research Inc. (grandviewresearch.com). The market is primarily driven by constant ...
Read More